WHO ICTRP trial
Induction chemotherapy with GP versus TPF in III-IVA nasopharyngeal carcinoma: a…
ChiCTR1900022288 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900022288 |
|---|---|
| Public title | Induction chemotherapy with GP versus TPF in III-IVA nasopharyngeal carcinoma: a randomized controlled trial |
| Scientific title | Induction chemotherapy with Gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil in III-IVA nasopharyngeal carcinoma: a non-inferiority, randomized phase 3 trial |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | nasopharyngeal carcinoma |
| Interventions | experimental group:gemcitabine + cisplatin;control group:docetaxel + cisplatin + fluorouracil |
| Registration date | Apr 3, 2019 |
| Target size | experimental group:189;control group:189 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: